Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis Julie FasanoTheresa ShaoCharles L. Shapiro Review 21 July 2020 Pages: 495 - 501
The histopathological and molecular features of breast carcinoma with tumour budding—a systematic review and meta-analysis Angus J. LloydÉanna J. RyanAoife J. Lowery Review 24 July 2020 Pages: 503 - 514
A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry Barbara L. SmithAnvy NguyenMichele A. Gadd Review 25 July 2020 Pages: 515 - 524
Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer Svetlana BortnikBasile Tessier-CloutierSharon M. Gorski Preclinical study 20 July 2020 Pages: 525 - 547
Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells Olga E. ChepikovaDmitry MalinVincent L. Cryns Preclinical study 21 July 2020 Pages: 549 - 564
Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice Genevieve V. DallJessica VieusseuxKara L. Britt Preclinical study 21 July 2020 Pages: 565 - 575
Patients with benign papilloma diagnosed on core biopsies and concordant pathology-radiology findings can be followed: experiences from multi-specialty high-risk breast lesion conferences in an academic center Zhongliang MaCletus A. ArcieroXiaoxian Li Preclinical study 23 July 2020 Pages: 577 - 584
Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer Andliena TahiriXavier TekpliVessela N. Kristensen Preclinical study Open access 24 July 2020 Pages: 585 - 598
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies Jing ZhaoJane MeiselXiaoxian Li Preclinical study 26 July 2020 Pages: 599 - 606
Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants Waleed S. Al AmriDiana E. BaxterThomas A. Hughes Preclinical study Open access 30 July 2020 Pages: 607 - 616
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy Arkadiusz Z. DudekLi C. LiuRuth M. O’Regan Clinical trial 22 July 2020 Pages: 617 - 627
The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer Helena HarderValerie M. ShillingLesley J. Fallowfield Clinical trial Open access 27 July 2020 Pages: 629 - 638
Pre-operative axillary ultrasound with fine-needle aspiration cytology performance and predictive factors of false negatives in axillary lymph node involvement in early breast cancer Judicael HottonJulia SalleronFrederic Marchal Clinical Trial 31 July 2020 Pages: 639 - 647
Financial toxicity and contralateral prophylactic mastectomy: an analysis using propensity score methods Malke AsaadStefanos BoukovalasAnaeze C. Offodile II Epidemiology 20 July 2020 Pages: 649 - 659
Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast Mary Kathryn AbelKelly Fahrner-ScottRita A. Mukhtar Epidemiology 21 July 2020 Pages: 661 - 667
Sarcoma of the breast: breast cancer history as etiologic and prognostic factor—A population-based case–control study Fredrik KarlssonFredrik GranathInga-Lena Nilsson Epidemiology Open access 21 July 2020 Pages: 669 - 675
Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes E. M. QuinnE. DunneS. M. Walsh Epidemiology 21 July 2020 Pages: 677 - 682
Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer Ning Yi YapNichole Yue Ting TanAlexandre Chan Epidemiology 21 July 2020 Pages: 683 - 696
Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer Se Hyun KimSoomin AhnJee Hyun Kim Epidemiology 26 July 2020 Pages: 697 - 704
Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial Vikki HoRomain Pasqueton behalf of the MAP3 Investigators Epidemiology 01 August 2020 Pages: 705 - 716
Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method Lize WangYingjian HeTao Ouyang Epidemiology 26 July 2020 Pages: 717 - 728
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer Sudpreeda ChainitikunJames P. LongNaoto T. Ueno Epidemiology 27 July 2020 Pages: 729 - 739
Diagnostic workup of early-stage breast cancer: can we choose more wisely? Rona AksShira Peleg HassonIdo Wolf Epidemiology 29 July 2020 Pages: 741 - 748
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115) Daniela Dornelles RosaJosé BinesSergio Daniel Simon Epidemiology 29 July 2020 Pages: 749 - 757
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study Emma J. GroenJan HudecekGrand Challenge PRECISION consortium Epidemiology Open access 30 July 2020 Pages: 759 - 770
Atypical lobular hyperplasia on core needle biopsy: contemporary results from a large community hospital breast program Dean LumleyDeidre StokesJohnny Kao Brief Report 23 July 2020 Pages: 771 - 774